Prostate cancer is the most common malignancy among men, accounting for around a third of all new cancer diagnoses each year. When detected early, before the disease has spread, it generally responds well to treatment, such as radiotherapy or prostatectomy. However, currently employed approaches for screening and early diagnosis have several drawbacks and have sometimes been a source of controversy.

To read more please complete and submit the form on the right.